Attached files
file | filename |
---|---|
8-K - FORM 8-K - NEUROLOGIX INC/DE | c09339e8vk.htm |
EX-10.5 - EXHIBIT 10.5 - NEUROLOGIX INC/DE | c09339exv10w5.htm |
EX-10.1 - EXHIBIT 10.1 - NEUROLOGIX INC/DE | c09339exv10w1.htm |
EX-99.1 - EXHIBIT 99.1 - NEUROLOGIX INC/DE | c09339exv99w1.htm |
EX-10.2 - EXHIBIT 10.2 - NEUROLOGIX INC/DE | c09339exv10w2.htm |
EX-10.3 - EXHIBIT 10.3 - NEUROLOGIX INC/DE | c09339exv10w3.htm |
EX-10.4 - EXHIBIT 10.4 - NEUROLOGIX INC/DE | c09339exv10w4.htm |
Exhibit 10.6
Neurologix, Inc.
One Bridge Plaza
Fort Lee, NJ 07024
One Bridge Plaza
Fort Lee, NJ 07024
November 23, 2010
Via Facsimile and Federal Express
To: The Investors Listed on the Signature Pages
Re: Proposed Financing
Ladies and Gentlemen:
Reference is made to (i) the Stock and Warrant Subscription Agreement, dated as of May 10,
2006, by and among Neurologix, Inc. (the Company), General Electric Pension Trust
(GE), DaimlerChrysler Corporation Master Retirement Trust, n/k/a Chrysler Group LLC
Master Retirement Trust (Chrysler), certain funds managed by ProMed Asset Management LLC,
Paul Scharfer, and David Musket (Musket), as amended by letter agreement dated November
8, 2007 (such Stock and Warrant Subscription Agreement, as amended, is hereafter referred to as the
Series C Subscription Agreement), (ii) the Stock and Warrant Subscription Agreement,
dated as of November 19, 2007, by and among the Company, GE and Corriente Master Fund, L.P. (the
Series D Subscription Agreement), and (iii) the Stock and Warrant Subscription Agreement,
dated as of April 28, 2008, by and among the Company, GE and Corriente Master Fund, L.P. (the
Corriente Subscription Agreement). Capitalized terms used but not defined herein shall
have the meanings set forth in the Series C Subscription Agreement, the Series D Subscription
Agreement and the Corriente Subscription Agreement.
As of the date hereof, each of GE, Chrysler, ProMed Partners, LP, ProMed Offshore Fund Ltd.
and Musket constitute all of the holders of the Companys Series C Convertible Preferred Stock, par
value $0.10 per share (each of GE, Chrysler, ProMed Partners LP, ProMed Offshore Fund Ltd. and
Musket is hereafter referred to individually as an Existing Series C Holder and
collectively as the Existing Series C Holders).
As of the date hereof, each of GE and Corriente Master Fund, L.P. (Corriente)
constitute all of the holders of the Companys Series D Convertible Preferred Stock, par value
$0.10 per share (each of GE and Corriente, in each such entitys respective capacity as a holder of
such shares, is hereafter referred to individually as an Existing Series D Holder and
collectively as the Existing Series D Holders).
As you know, the Company is proposing to issue senior secured promissory notes and common
stock warrants on substantially the terms set forth in the letter of intent attached hereto as
Exhibit A (the issuance of such notes and warrants on such terms is hereafter referred to
as the Financing). You are either participating in, or have waived your rights to
participate in, the Financing.
One of the Financing terms provides that the investors participating in the Financing (the
Financing Investors) be given the right to participate in certain future financings of
the Company in an amount equal to the greater of (i) nineteen percent (19%) of the aggregate amount
of securities offered in such financing and (ii) the amount of such offered securities not
subscribed for by the Companys existing preemptive rights holders (such participation right is
hereafter referred to as the Financing Right of First Refusal).
Sections 3.1 of the Series C Subscription Agreement, the Series D Subscription Agreement and
the Corriente Subscription Agreement provide the Existing Series C Holders and the Existing Series
D Holders with participation rights in future equity or equity-related financings of the Company
(such participation rights are hereafter referred to as the Existing Right of First
Refusal).
In order to permit the Company to comply with the Financing Right of First Refusal, the
Company is hereby requesting your consent to the following modifications to Section 3.1 of the
Series C Subscription Agreement, the Series D Subscription Agreement and the Corriente Subscription
Agreement:
Modifications:
You hereby acknowledge and agree that any Offered Securities for which you may subscribe, as
set forth in your Notice of Acceptance, shall be reduced to the extent necessary for the Company to
comply with the Financing Right of First Refusal; provided, that, any such
reduction shall be made on a pro rata basis among all other participating Existing Series C Holders
and Existing Series D Holders based on each such Holders participation amount as set forth in its
Notice of Acceptance; and provided, further, that, any such reduction shall
first be made to any Undersubscription Amounts on a pro rata basis among the oversubscribing
Existing Series C Holders and Existing Series D Holders based on each such Holders
Undersubscription Amount as set forth in its Notice of Acceptance.
Sections 6.2 of the Series C Subscription Agreement and the Series D Subscription Agreement
and Section 7.2 of the Corriente Subscription Agreement require your consent to the modifications
described in the preceding paragraph. Your acknowledgment below indicates your consent to such
modifications and your acceptance of and agreement to the matters set forth herein. Accordingly,
please sign the copy of this letter enclosed for such purpose in the designated space below and
return it to the Company by e-mail to marcpanoff@neurologix.net, or by facsimile to (201) 592-0366,
attention: Marc Panoff, Chief Financial Officer.
This letter shall be governed by, and construed in accordance with, the internal laws of the
State of New York, without regard to the choice of law principles thereof.
This letter may be executed in two or more counterparts, each of which shall constitute an
original, but all of which, when taken together, shall constitute but one instrument.
Sincerely,
/s/ Marc L.
Panoff
Marc L. Panoff
Chief Financial Officer
Marc L. Panoff
Chief Financial Officer
Consented and Accepted: | ||||
Investors: | ||||
GENERAL ELECTRIC PENSION TRUST | ||||
By: GE Asset Management Incorporated, its Investment Manager |
||||
By: |
/s/ B.C. Sophia Tsai | |||
Title: Vice President and Managing Director | ||||
CHRYSLER GROUP LLC MASTER RETIREMENT TRUST | ||||
By: State Street Bank and Trust Company, as Trustee of the Chrysler Group LLC Master Retirement Trust | ||||
By: |
/s/ Steve Sovany | |||
Name: Steve Sovany | ||||
Title: Vice President | ||||
PROMED PARTNERS, LP | ||||
By: |
/s/ David Musket | |||
Name: David Musket | ||||
Title: GP | ||||
PROMED OFFSHORE FUND LTD. | ||||
By: |
/s/ David Musket | |||
Name: David Musket | ||||
Title: Managing Member | ||||
CORRIENTE MASTER FUND, L.P. | ||||
By: Corriente Capital Management, L.P., its Managing General Partner |
||||
By: Corriente Advisors, LLC, its General Partner |
||||
By: |
/s/ James Haddaway | |||
Name: James Haddaway | ||||
Title: President | ||||
/s/ David Musket | ||||
David Musket |